Molecular Mechanism of PP2A/B55α Phosphatase Inhibition by IER5

Overview

Journal bioRxiv

Date 2023 Sep 11

PMID 37693604

Authors

Ruili Cao

Daniel Td Jones

Li Pan

Annie Yang

Shumei Wang

Sathish K R Padi

Shaun Rawson

Jon C Aster

Stephen C Blacklow

Affiliations

Soon will be listed here.

Abstract

PP2A serine/threonine phosphatases are heterotrimeric complexes that execute many essential physiologic functions. These activities are modulated by additional regulatory proteins, such as ARPP19, FAM122A, and IER5. Here, we report the cryoelectron microscopy structure of a complex of PP2A/B55α with the N-terminal structured region of IER5 (IER5-N50), which occludes a surface on B55α used for substrate recruitment, and show that IER5-N50 inhibits PP2A/B55α catalyzed dephosphorylation of pTau in biochemical assays. Mutations of full-length IER5 that disrupt its PP2A/B55α interface interfere with co-immunoprecipitation of PP2A/B55α. These mutations and deletions that remove the nuclear localization sequence of IER5 suppress cellular events such as expression that depend on association of IER5 with PP2A/B55α. Querying the Alphafold2 predicted structure database identified SERTA domain proteins as high-confidence PP2A/B55α-binding structural homologs of IER5-N50. These studies define the molecular basis of PP2A/B55α inhibition by IER5-family proteins and suggest a roadmap for selective pharmacologic modulation of PP2A/B55α complexes.

References

Mochida S, Maslen S, Skehel M, Hunt T . Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science. 2010; 330(6011):1670-3. DOI: 10.1126/science.1195689. View

Punjani A, Rubinstein J, Fleet D, Brubaker M . cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017; 14(3):290-296. DOI: 10.1038/nmeth.4169. View

Asano Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Tatebe S . IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis. Sci Rep. 2016; 6:19174. PMC: 4709660. DOI: 10.1038/srep19174. View

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O . Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-589. PMC: 8371605. DOI: 10.1038/s41586-021-03819-2. View

Xu Y, Chen Y, Zhang P, Jeffrey P, Shi Y . Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol Cell. 2008; 31(6):873-85. PMC: 2818795. DOI: 10.1016/j.molcel.2008.08.006. View

Wasserman J, Faezov B, Patel K, Kurimchak A, Palacio S, Glass D . FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nat Commun. 2024; 15(1):5776. PMC: 11233601. DOI: 10.1038/s41467-024-50015-7. View

Schmid E, Walter J . Predictomes, a classifier-curated database of AlphaFold-modeled protein-protein interactions. Mol Cell. 2025; . DOI: 10.1016/j.molcel.2025.01.034. View

Pan L, Lemieux M, Thomas T, Rogers J, Lipper C, Lee W . , a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. Elife. 2020; 9. PMC: 7529455. DOI: 10.7554/eLife.58081. View

Kis E, Szatmari T, Keszei M, Farkas R, Esik O, Lumniczky K . Microarray analysis of radiation response genes in primary human fibroblasts. Int J Radiat Oncol Biol Phys. 2006; 66(5):1506-14. DOI: 10.1016/j.ijrobp.2006.08.004. View

10.

Cho J, Song D, Bergeron J, Benlimame N, Wold M, Alaoui-Jamali M . RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A. Nucleic Acids Res. 2000; 28(18):3478-85. PMC: 110737. DOI: 10.1093/nar/28.18.3478. View

11.

Letourneux C, Rocher G, Porteu F . B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 2006; 25(4):727-38. PMC: 1383561. DOI: 10.1038/sj.emboj.7600980. View

12.

Ronk H, Rosenblum J, Kung T, Zhuang Z . Targeting PP2A for cancer therapeutic modulation. Cancer Biol Med. 2022; 19(10). PMC: 9630519. DOI: 10.20892/j.issn.2095-3941.2022.0330. View

13.

Williams C, Headd J, Moriarty N, Prisant M, Videau L, Deis L . MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2017; 27(1):293-315. PMC: 5734394. DOI: 10.1002/pro.3330. View

14.

Zheng H, Qi Y, Hu S, Cao X, Xu C, Yin Z . Identification of Integrator-PP2A complex (INTAC), an RNA polymerase II phosphatase. Science. 2020; 370(6520). DOI: 10.1126/science.abb5872. View

15.

Yamashita K, Palmer C, Burnley T, Murshudov G . Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr D Struct Biol. 2021; 77(Pt 10):1282-1291. PMC: 8489229. DOI: 10.1107/S2059798321009475. View

16.

Yamano S, Kimura M, Chen Y, Imamoto N, Ohki R . Nuclear import of IER5 is mediated by a classical bipartite nuclear localization signal and is required for HSF1 full activation. Exp Cell Res. 2019; 386(1):111686. DOI: 10.1016/j.yexcr.2019.111686. View

17.

Bryant P, Pozzati G, Elofsson A . Improved prediction of protein-protein interactions using AlphaFold2. Nat Commun. 2022; 13(1):1265. PMC: 8913741. DOI: 10.1038/s41467-022-28865-w. View

18.

Hsu S, Yang C, Sim K, Hentschel D, OLeary E, Bonventre J . TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J. 2001; 20(9):2273-85. PMC: 125435. DOI: 10.1093/emboj/20.9.2273. View

19.

Nicholls R, Long F, Murshudov G . Low-resolution refinement tools in REFMAC5. Acta Crystallogr D Biol Crystallogr. 2012; 68(Pt 4):404-17. PMC: 3322599. DOI: 10.1107/S090744491105606X. View

20.

Fischer E, Bohm K, Lydeard J, Yang H, Stadler M, Cavadini S . Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014; 512(7512):49-53. PMC: 4423819. DOI: 10.1038/nature13527. View